Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Pancreatic cancer (2)
- Atherosclerosis (1)
- Bioactive compounds (1)
- Biogenesis (1)
- Biomarker (1)
-
- Cancer (1)
- Cercopithecidae (1)
- Cytochrome c (1)
- Dentition (1)
- Diabetes (1)
- Diabetic retinopathy (1)
- Drug delivery (1)
- Evolution (1)
- Fatty acids (1)
- Fruitflow® (1)
- Genotype:phenotype mapping (1)
- Human blood platelets (1)
- Hypertension (1)
- Inflammation (1)
- Kiwi fruit (1)
- Monkeys (1)
- Non-hemostatic function (1)
- Obesity (1)
- Paclitaxel nanomedicine (1)
- Pancreatic ductal adenocarcinoma (1)
- Phylogeny (1)
- Polyphenols (1)
- Primates (1)
- Ribosome (1)
- Tumor microenvironment (1)
- Publication
- Publication Type
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Bioactive Food Components And Their Inhibitory Actions In Multiple Platelet Pathways, Diptimayee Das, Shubhamay Adhikary, Ranjit Kumar Das, Antara Banerjee, Arun Kumar Radhakrishnan, Sujay Paul, Surajit Pathak, Asim K. Duttaroy
Bioactive Food Components And Their Inhibitory Actions In Multiple Platelet Pathways, Diptimayee Das, Shubhamay Adhikary, Ranjit Kumar Das, Antara Banerjee, Arun Kumar Radhakrishnan, Sujay Paul, Surajit Pathak, Asim K. Duttaroy
Health & Biomedical Sciences Faculty Publications and Presentations
In addition to hemostasis and thrombosis, blood platelets are involved in various processes such as inflammation, infection, immunobiology, cancer metastasis, wound repair and angiogenesis. Platelets' hemostatic and non-hemostatic functions are mediated by the expression of various membrane receptors and the release of proteins, ions and other mediators. Therefore, specific activities of platelets responsible for the non-hemostatic disease are to be inhibited while leaving the platelet's hemostatic function unaffected. Platelets' anti-aggregatory property has been used as a primary criterion for antiplatelet drugs/bioactives; however, their non-hemostatic activities are not well known. This review describes the hemostatic and non-hemostatic function of human blood …
Keeping 21st Century Paleontology Grounded: Quantitative Genetic Analyses And Ancestral State Reconstruction Re-Emphasize The Essentiality Of Fossils, Tesla A. Monson, Marianne F. Brasil, Michael Mahaney, Christopher A. Schmitt, Catherine E. Taylor, Leslea J. Hlusko
Keeping 21st Century Paleontology Grounded: Quantitative Genetic Analyses And Ancestral State Reconstruction Re-Emphasize The Essentiality Of Fossils, Tesla A. Monson, Marianne F. Brasil, Michael Mahaney, Christopher A. Schmitt, Catherine E. Taylor, Leslea J. Hlusko
School of Medicine Publications and Presentations
Advances in genetics and developmental biology are revealing the relationship between genotype and dental phenotype (G:P), providing new approaches for how paleontologists assess dental variation in the fossil record. Our aim was to understand how the method of trait definition influences the ability to reconstruct phylogenetic relationships and evolutionary history in the Cercopithecidae, the Linnaean Family of monkeys currently living in Africa and Asia. We compared the two-dimensional assessment of molar size (calculated as the mesiodistal length of the crown multiplied by the buccolingual breadth) to a trait that reflects developmental influences on molar development (the inhibitory cascade, IC) and …
Cytochrome C: A Potential Early Biomarker Of Diabetic Retinopathy, Ileana G. Villarreal
Cytochrome C: A Potential Early Biomarker Of Diabetic Retinopathy, Ileana G. Villarreal
Biology Dissertations and Theses
Diabetic retinopathy is an ocular disease which appears in patients who experience progression of diabetes mellitus over a continuous period of time. Oftentimes, patients remain undiagnosed through the first stages of diabetic retinopathy due to the fact that there is not a specific way to determine when a patient develops the disease. Ophthalmologists and other eye specialists diagnose a patient with diabetic retinopathy once the patient begins to show progressed symptoms of the disease. Previous experiments have been performed to increase our knowledge of diabetic retinopathy and early biomarkers of the disease. Several studies have determined the effects of diabetic …
Targeting Ribosome Biogenesis For Pancreatic Cancer Treatment, Carlos Perez Iii
Targeting Ribosome Biogenesis For Pancreatic Cancer Treatment, Carlos Perez Iii
Theses and Dissertations
Pancreatic cancer (PanCa) is one of the leading causes of cancer-related death in the United States. Currently, PanCa is one of the recalcitrant cancers that has very limited therapeutic options available for its treatment. The current standard care of PanCa is gemcitabine (GEM) alone or in combination with FOLFIRINOX, nab-paclitaxel, erlotinib, or 5-FU PanCa, which often show poor response. Therefore, new treatment strategies are required for the prevention and treatment of cancer. Ribosome biogenesis process is dysregulated in most of the cancer types of results in production of more ribosomes and synthesis of oncoproteins which lead to the induction, progression, …
Influence Of Paclitaxel Nanomedicine On The Pancreatic Tumor Immune Components, Godwin Peasah-Darkwah
Influence Of Paclitaxel Nanomedicine On The Pancreatic Tumor Immune Components, Godwin Peasah-Darkwah
Theses and Dissertations
Pancreatic cancer (PanCa) is one of the leading causes of cancer-related mortalities in the U.S due to ineffective therapeutic options. Pancreatic tumors are highly desmoplastic and inhibit efficient uptake of therapeutic payloads. Paclitaxel (PTX) has been tested in PanCa therapy with marginally better clinical outcomes, but remain limited by its poor hemocompatibility, biodistribution and intracellular accumulation in tumor cells. Thus, we synthesized a next generation nanoparticle system for PTX to improve its pharmacokinetics and pharmacodynamics (PKPD) in treating PanCa. We also examined ability of the nano formulation to potentiate gemcitabine (GEM) activity in combating chemoresistance in the pancreatic tumor microenvironment …